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PandemicThe ongoing coronavirus disease 2019 (COVID-19) outbreakmay be
associated with direct and indirect adverse consequences on the heart.
Besides severe pneumonia, myocarditis and myocardial injury have
been suspected as additional causes of death in patients affected by
COVID-19 [1]. However, as recently reported by Q. Deng et al. troponin⁎ Corresponding author at: Division of Cardiology, Fondazione IRCCS Policlinico San
Matteo, viale Golgi 19, 27100 Pavia, Italy.
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0167-5273/© 2020 Elsevier B.V. All rights reserved.levels were increased particularly in patients who died during hospital-
ization although they did not present with typical signs of myocarditis
[2].
Another indirect consequence of this pandemic is the way in which
it may adversely affect the efficiency and effectiveness of the network
organization required to offer primary percutaneous coronary interven-
tion (PPCI) to the patients presenting with ST-elevation myocardial in-
farction (STEMI), within appropriate time frames. There are already
reports from China of delays in the presentation and treatment of
STEMI [3] which may eventually exert an indirect disruptive impact
on outcomes.
Recommendations on how to treat STEMI patients with or without a
COVID-19 infection have been issued in countries with a massive virus
outbreak [4].
Lombardy is the most densely populated region in Italy, with ap-
proximately 10 million inhabitants, and is at the moment striving with
COVID-19. With regard to the STEMI network, the healthcare system
is divided in 8 areas, with an overall availability of 55 catheterization
laboratories, performing 24/7 PPCI (Fig. 1) and a well established net-
work for the treatment of STEMI. Since February 21st 2020, healthcare
operators in the region faced an exponential rise of COVID-19 patients,
leading to an increased number of subjects requiring hospitalization,
and a subsequent overload of the intensive care units (ICUs).
To face the emergency, most hospitals underwent a sudden, yet rad-
ical, transformation: all deferrable surgical and interventional
Fig. 1.Map with geographical location of the eight areas of the Lombardy Region with the estimated resident population: 1 (mountain region, 298,000); 2 (1,145,000); 3 (1,115,000); 4
(1,200,000); 5 (1,430,000); 6 (773,000); 7 (3,480,000); 8 (546,000). SO=Sondrio; BS=Brescia; BG=Bergamo; LC= Lecco;MB=Monza; VA=Varese;MN=Mantova;MI=Milano;
PV=Pavia. The squares indicate the “Macro-hubs” identified during the pandemic. The full circles represent the “hub” hospitals before the pandemic that have been converted to spoke.
The empty circles represent hospitals that were “spoke” even before the outbreak. Arrows indicate the referral “macro-hub” of each spoke.
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tially increased, and most departments (including coronary care units)
were converted to COVID-19 units.
On March 8th, the decree of the healthcare Authorities of Lom-
bardy [5] urged a change in all the regional networks for the treat-
ment of time-dependent clinical and surgical emergencies (STEMI,
stroke, major traumas, neurological, cardiac and vascular surgical
emergencies) to concentrate personnel and urgent activities in few
centers while expanding health resources for COVID-19 patients,
and simultaneously to avoid default of hospitals due to general
overload.
A model of centralization to some “Macro-Hubs” was applied: for
patients with STEMI, one or two Macro-Hub were identified in each
area, according to the estimated transportation time of patients, geo-
graphical features and capacity to admit all the potential patients. The
following requirements were further considered for potential Macro-
hubs: to perform PPCI to all incoming STEMI, 24/7; to guarantee a
PPCI team (interventional cardiologists, nurses and related staff) that
would be available in hospital 24/7 and not on call; to provide internal,
dedicated and separated, pathways for STEMI patients with suspected/
diagnosed COVID-19 disease from triage, through catheterization labo-
ratory to isolated care units, in order to reduce cross-infection rate at
each step of the care process, and to guarantee a convenient protection
of the healthcare professionals. Finally, the staff of the spoke hospitals
were required to cooperate with the hub, to deliver the aforementioned
level of care.Thus, thirteen “Macro-hub”were identified, with a 63% reduction in
the number of hubs compared to pre-pandemic setting; the number of
spoke centers permacro-hubwas different inside each area (Fig. 1). This
model of STEMI centralization was established to keep the regional
healthcare system from being overwhelmed, and to guarantee at the
same time standard levels of care to the patients trying to prevent the
indirect adverse outcome on the heart related to the COVID-19 out-
break. Although this system may not be entirely applicable to different
geographical areas or preexisting networks, it may portend a model
for other countries. The disease is spreading, and every State should
be prepared even to drastic pre-emptive actions tomaintain the quality
of STEMI care [6]. Staring at the sea is not the best strategy to fight a
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